Growing placebo response in TMS treatment for depression: a meta-analysis of 27-year randomized sham-controlled trials

[1]  Zheng Wang,et al.  Effects of neuronavigation-guided rTMS on serum BDNF, TrkB and VGF levels in depressive patients with suicidal ideation. , 2022, Journal of affective disorders.

[2]  Z. Deng,et al.  Modelling the differential effects of age on transcranial magnetic stimulation induced electric fields , 2022, Journal of neural engineering.

[3]  R. Goya-Maldonado,et al.  Suicidality and relief of depressive symptoms with intermittent theta burst stimulation in a sham‐controlled randomized clinical trial , 2022, Acta psychiatrica Scandinavica.

[4]  Lei Zhang,et al.  Repetitive transcranial magnetic stimulation promotes response inhibition in patients with major depression during the stop-signal task. , 2022, Journal of psychiatric research.

[5]  Emily Pedersen,et al.  Age as a determinant of transcranial magnetic stimulation efficacy for major depressive disorder in a naturalistic clinic setting , 2022, Brain Stimulation.

[6]  L. Colloca,et al.  The neglect of sex: A call to action for including sex as a biological variable in placebo and nocebo research. , 2022, Contemporary clinical trials.

[7]  Á. Pascual-Leone,et al.  Placebo effects and neuromodulation for depression: a meta-analysis and evaluation of shared mechanisms , 2021, Molecular Psychiatry.

[8]  A. Frick,et al.  Habitual caffeine consumption moderates the antidepressant effect of dorsomedial intermittent theta-burst transcranial magnetic stimulation , 2021, Journal of psychopharmacology.

[9]  I. Bennett,et al.  Bridging patterns of neurocognitive aging across the older adult lifespan , 2021, Neuroscience & Biobehavioral Reviews.

[10]  Xinfu He,et al.  High-frequency repetitive transcranial magnetic stimulation (rTMS) accelerates onset time of beneficial treating effects and improves clinical symptoms of depression. , 2021, CNS & neurological disorders drug targets.

[11]  J. Ricardo-Garcell,et al.  Two rTMS sessions per week: a practical approach for treating major depressive disorder , 2021, Neuroreport.

[12]  R. Kessler,et al.  The Genetic Architecture of Depression in Individuals of East Asian Ancestry , 2021, JAMA psychiatry.

[13]  B. Millet,et al.  The priming effect of repetitive transcranial magnetic stimulation on clinical response to electroconvulsive therapy in treatment-resistant depression: a randomized, double-blind, sham-controlled study , 2021, Psychological Medicine.

[14]  B. Mulsant,et al.  Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults , 2021, JAMA network open.

[15]  C. Juhl,et al.  Placebo response and effect in randomized clinical trials: meta-research with focus on contextual effects , 2021, Trials.

[16]  A. Aleman,et al.  No antidepressant effects of low intensity transcranial pulsed electromagnetic fields for treatment resistant depression. , 2021, Journal of affective disorders.

[17]  A. Brunoni,et al.  Treatment of mixed depression with theta-burst stimulation (TBS): results from a double-blind, randomized, sham-controlled clinical trial , 2021, Neuropsychopharmacology.

[18]  T. Bai,et al.  Therapeutic efficacy of connectivity‐directed transcranial magnetic stimulation on anticipatory anhedonia , 2021, Depression and anxiety.

[19]  J Zhang,et al.  Impact of Repetitive Transcranial Magnetic Stimulation (rTMS) on Theory of Mind and Executive Function in Major Depressive Disorder and Its Correlation with Brain-Derived Neurotrophic Factor (BDNF): A Randomized, Double-Blind, Sham-Controlled Trial , 2021, Brain sciences.

[20]  A. Serrano-Blanco,et al.  Prevalence and variability of current depressive disorder in 27 European countries: a population-based study , 2021, The Lancet. Public health.

[21]  Cheng-Ta Li,et al.  Task-Modulated Brain Activity Predicts Antidepressant Responses of Prefrontal Repetitive Transcranial Magnetic Stimulation: A Randomized Sham-Control Study , 2021, Chronic stress.

[22]  Georgios Mikellides,et al.  Repetitive transcranial magnetic stimulation: an innovative medical therapy. , 2021, Psychiatrike = Psychiatriki.

[23]  D. Obregon,et al.  Interactions of the Placebo Effect and Transcranial Magnetic Stimulation. , 2021, The primary care companion for CNS disorders.

[24]  A. Zandvakili,et al.  Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: Recent Critical Advances in Patient Care , 2021, Current Treatment Options in Psychiatry.

[25]  R. Shansky,et al.  Considering sex as a biological variable will require a global shift in science culture , 2021, Nature Neuroscience.

[26]  S. Rossi,et al.  Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines , 2020, Clinical Neurophysiology.

[27]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[28]  M. Demitrack,et al.  Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial , 2020, Neuropsychopharmacology.

[29]  Xinfu He,et al.  The therapeutic effect of repetitive transcranial magnetic stimulation in elderly depression patients , 2020, Medicine.

[30]  J. Persson,et al.  Modulation of the prefrontal blood oxygenation response to intermittent theta-burst stimulation in depression: A sham-controlled study with functional near-infrared spectroscopy , 2020, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[31]  C. Tsai,et al.  Antidepressant efficacy and immune effects of bilateral theta burst stimulation monotherapy in major depression: A randomized, double-blind, sham-controlled study , 2020, Brain, Behavior, and Immunity.

[32]  Zhijun Zhang,et al.  Task-related functional magnetic resonance imaging-based neuronavigation for the treatment of depression by individualized repetitive transcranial magnetic stimulation of the visual cortex , 2020, Science China Life Sciences.

[33]  M. Fox,et al.  Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression , 2020, Biological Psychiatry.

[34]  Shangda Li,et al.  Neuronavigation‐Guided rTMS for the Treatment of Depressive Patients With Suicidal Ideation: A Double‐Blind, Randomized, Sham‐Controlled Trial , 2020, Clinical pharmacology and therapeutics.

[35]  Miriam H. A. Bopp,et al.  Intermittent theta-burst stimulation moderates interaction between increment of N-Acetyl-Aspartate in anterior cingulate and improvement of unipolar depression , 2020, Brain Stimulation.

[36]  M. Shigeta,et al.  Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial , 2020, Neuropsychobiology.

[37]  P. Coyte,et al.  Cost–Utility Analysis of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Ontario , 2019, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[38]  S. Kennedy,et al.  Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial , 2019, Brain Stimulation.

[39]  Cochrane Handbook for Systematic Reviews of Interventions Edited by Julian P. T. Higgins & , 2006 .

[40]  P. Zis,et al.  The neurobiology under the placebo effect. , 2019, Drugs of today.

[41]  F. Franconi,et al.  Sex-Gender Variable: Methodological Recommendations for Increasing Scientific Value of Clinical Studies , 2019, Cells.

[42]  P. Enck,et al.  Does Sex/Gender Play a Role in Placebo and Nocebo Effects? Conflicting Evidence From Clinical Trials and Experimental Studies , 2019, Front. Neurosci..

[43]  P. Manganotti,et al.  Dramatic placebo effect of high frequency repetitive TMS in treatment of chronic migraine and medication overuse headache , 2019, Journal of Clinical Neuroscience.

[44]  Á. Pascual-Leone,et al.  Challenges of differential placebo effects in contemporary medicine: The example of brain stimulation , 2019, Annals of neurology.

[45]  Matthew R. Krause,et al.  Immediate neurophysiological effects of transcranial electrical stimulation , 2018, Nature Communications.

[46]  Grant D. Huang,et al.  Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans: A Randomized Clinical Trial , 2018, JAMA psychiatry.

[47]  Liang-Jen Wang,et al.  Efficacy of repetitive transcranial magnetic stimulation for Tourette syndrome: A systematic review and meta-analysis , 2018, Brain Stimulation.

[48]  A. Zangen,et al.  Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial , 2018, Neuropsychopharmacology.

[49]  Andrew L. Geers,et al.  Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus , 2018, Psychotherapy and Psychosomatics.

[50]  F. Fregni,et al.  A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials , 2018, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[51]  A. Foundas,et al.  Unilateral repetitive transcranial magnetic stimulation differentially affects younger and older adults completing a verbal working memory task , 2018, Journal of the Neurological Sciences.

[52]  W. McDonald,et al.  rTMS with a two-coil array: Safety and efficacy for treatment resistant major depressive disorder , 2017, Brain Stimulation.

[53]  T. Paparrigopoulos,et al.  Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial , 2017, The journal of ECT.

[54]  Lin Lu,et al.  Randomized controlled trial of repetitive transcranial magnetic stimulation combined with paroxetine for the treatment of patients with first-episode major depressive disorder , 2017, Psychiatry Research.

[55]  J. Loscalzo,et al.  Network analysis of the genomic basis of the placebo effect. , 2017, JCI insight.

[56]  W. Brown,et al.  Has the rising placebo response impacted antidepressant clinical trial outcome? Data from the US Food and Drug Administration 1987‐2013 , 2017, World psychiatry : official journal of the World Psychiatric Association.

[57]  Luke J. Chang,et al.  Brain Mechanisms of the Placebo Effect: An Affective Appraisal Account. , 2017, Annual review of clinical psychology.

[58]  J. Haro,et al.  Epidemiology of depression with psychotic experiences and its association with chronic physical conditions in 47 low- and middle-income countries , 2016, Psychological Medicine.

[59]  G. Pourtois,et al.  Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission? , 2016, Journal of affective disorders.

[60]  B. Mulsant,et al.  Unilateral and bilateral MRI-targeted repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled study. , 2016, Journal of psychiatry & neuroscience : JPN.

[61]  D. Rubinow.  Sex, Drugs, and the Neurobiology of the Placebo Effect , 2016, Biological Psychiatry.

[62]  A. Carvalho,et al.  Bias in Peripheral Depression Biomarkers , 2016, Psychotherapy and Psychosomatics.

[63]  K. Nguyen,et al.  Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[64]  J. O'reardon,et al.  Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression , 2015, Brain Stimulation.

[65]  T. Kaptchuk,et al.  Placebo Effects in Medicine. , 2015, The New England journal of medicine.

[66]  Minmin Xie,et al.  Efficacy and safety of the Chinese herbal medicine shuganjieyu with and without adjunctive repetitive transcranial magnetic stimulation (rTMS) for geriatric depression: a randomized controlled trial , 2015, Shanghai archives of psychiatry.

[67]  E. Hollander,et al.  Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial , 2015, World psychiatry : official journal of the World Psychiatric Association.

[68]  P. Enck,et al.  Age and Sex as Moderators of the Placebo Response - An Evaluation of Systematic Reviews and Meta-Analyses across Medicine , 2014, Gerontology.

[69]  S. Rossi,et al.  Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) , 2014, Clinical Neurophysiology.

[70]  David Szekely,et al.  The Efficacy and Safety of Low Frequency Repetitive Transcranial Magnetic Stimulation for Treatment-resistant Depression: The Results From a Large Multicenter French RCT , 2014, Brain Stimulation.

[71]  F. Benedetti,et al.  Placebo and Nocebo Effects , 2014 .

[72]  Martin Krzywinski,et al.  Points of significance: Power and sample size , 2013, Nature Methods.

[73]  S. Potkin,et al.  Meta-regression analysis of placebo response in antipsychotic trials, 1970-2010. , 2013, The American journal of psychiatry.

[74]  Alvaro Pascual-Leone,et al.  Challenges of proper placebo control for non‐invasive brain stimulation in clinical and experimental applications , 2013, The European journal of neuroscience.

[75]  S. Roose,et al.  A model of placebo response in antidepressant clinical trials. , 2013, The American journal of psychiatry.

[76]  A. Sartorius,et al.  Ultra-High-Frequency Left Prefrontal Transcranial Magnetic Stimulation as Augmentation in Severely Ill Patients with Depression: A Naturalistic Sham-Controlled, Double-Blind, Randomized Trial , 2012, Neuropsychobiology.

[77]  B. Mulsant,et al.  A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[78]  P. Fitzgerald,et al.  A double blind randomized trial of unilateral left and bilateral prefrontal cortex transcranial magnetic stimulation in treatment resistant major depression. , 2012, Journal of affective disorders.

[79]  C. Wöber,et al.  Quality of Life, Depression, and Anxiety 6 Months After Inpatient Withdrawal in Patients With Medication Overuse Headache: An Observational Study , 2012, The Clinical journal of pain.

[80]  Shao-hua Hu,et al.  Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: A double-blind, randomized, sham-controlled trial , 2012, The Australian and New Zealand journal of psychiatry.

[81]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[82]  Klaus Martiny,et al.  Transcranial Low Voltage Pulsed Electromagnetic Fields in Patients with Treatment-Resistant Depression , 2010, Biological Psychiatry.

[83]  S. Pallanti,et al.  Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression? , 2010, Neuroscience.

[84]  H. Sackeim,et al.  Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. , 2010, Archives of general psychiatry.

[85]  T. Kaptchuk,et al.  Biological, clinical, and ethical advances of placebo effects , 2010, The Lancet.

[86]  S. Rossi,et al.  Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research , 2009, Clinical Neurophysiology.

[87]  Robert E. Slavin,et al.  The Relationship Between Sample Sizes and Effect Sizes in Systematic Reviews in Education , 2009 .

[88]  Wang Xinyi,et al.  Effects of repetitive transcranial magnetic stimulation on hypothalamic-pituitary-adrenal axis of patients with depression , 2009 .

[89]  S. Hofmann,et al.  Meta-analysis of the placebo response in antidepressant trials. , 2009, Journal of affective disorders.

[90]  David A Seminowicz,et al.  The Anatomy of the Mesolimbic Reward System: A Link between Personality and the Placebo Analgesic Response , 2009, The Journal of Neuroscience.

[91]  F. Fregni,et al.  Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-Analysis , 2009, PloS one.

[92]  A. Hackshaw,et al.  Small studies: strengths and limitations , 2008, European Respiratory Journal.

[93]  Fabrizio Benedetti,et al.  New Insights into the Placebo and Nocebo Responses , 2008, Neuron.

[94]  P. Bech,et al.  Repetitive Transcranial Magnetic Stimulation (rTMS) in Combination with Escitalopram in Patients with Treatment-Resistant Major Depression. A Double-Blind, Randomised, Sham-Controlled Trial , 2008, Pharmacopsychiatry.

[95]  William W. McDonald,et al.  Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial , 2007, Biological Psychiatry.

[96]  Christoph Laske,et al.  Antidepressant effects of augmentative transcranial magnetic stimulation , 2007, British Journal of Psychiatry.

[97]  R. Kravitz,et al.  Depression , 2007, Annals of Internal Medicine.

[98]  S. Rhodes.  Publication Bias in Meta-analysis by H. R. Rothstein, A. J. Sutton and M. Borenstein (eds) , 2006 .

[99]  M. Borenstein,et al.  Publication Bias in Meta-Analysis , 2006 .

[100]  J. Neumaier,et al.  A Controlled Study of Repetitive Transcranial Magnetic Stimulation in Medication-Resistant Major Depression , 2006, Biological Psychiatry.

[101]  E. Smeraldi,et al.  Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial. , 2005, The Journal of clinical psychiatry.

[102]  J. Zubieta,et al.  Neurobiological Mechanisms of the Placebo Effect , 2005, The Journal of Neuroscience.

[103]  Sergio P. Rigonatti,et al.  Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: A double-blind placebo-controlled study , 2005, Biological Psychiatry.

[104]  M. V. van Duijn,et al.  A 3-month, follow-up, randomized, placebo-controlled study of repetitive transcranial magnetic stimulation in depression. , 2004, The Journal of clinical psychiatry.

[105]  P. Fitzgerald,et al.  Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. , 2003, Archives of general psychiatry.

[106]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[107]  J. Edinger,et al.  A primary care "friendly" cognitive behavioral insomnia therapy. , 2003, Sleep.

[108]  Ted J. Kaptchuk,et al.  The Placebo Effect in Alternative Medicine: Can the Performance of a Healing Ritual Have Clinical Significance? , 2002, Annals of Internal Medicine.

[109]  R. Sysko,et al.  Placebo response in studies of major depression: variable, substantial, and growing. , 2002, JAMA.

[110]  Christian Gluud,et al.  Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses , 2001, Annals of Internal Medicine.

[111]  J. Sterne,et al.  Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. , 2000, Journal of clinical epidemiology.

[112]  T. Kaptchuk,et al.  Do medical devices have enhanced placebo effects? , 2000, Journal of clinical epidemiology.

[113]  D. Moerman.  Cultural variations in the placebo effect: ulcers, anxiety, and blood pressure. , 2000, Medical anthropology quarterly.

[114]  M Feinsod,et al.  Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. , 1999, Archives of general psychiatry.

[115]  H. Kiene,et al.  The powerful placebo effect: fact or fiction? , 1997, Journal of clinical epidemiology.

[116]  R. Tweedie,et al.  Publication Bias in Meta-Analysis: A Bayesian Data-Augmentation Approach to Account for Issues Exempli(cid:12)ed in the Passive Smoking Debate , 1997 .

[117]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[118]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[119]  T. Herzog,et al.  Psychotherapy of bulimia nervosa: what is effective? A meta-analysis. , 1992, Journal of psychosomatic research.

[120]  P. Lachenbruch.  Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[121]  Betsy Jane Becker,et al.  Synthesizing standardized mean‐change measures , 1988 .

[122]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[123]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[124]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[125]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[126]  R. Zachariae,et al.  Placebo and Active Treatment Additivity in Placebo Analgesia: Research to Date and Future Directions. , 2018, International review of neurobiology.

[127]  J. Rapoport,et al.  Child Psychiatry Branch of the National Institute of Mental Health Longitudinal Structural Magnetic Resonance Imaging Study of Human Brain Development , 2015, Neuropsychopharmacology.

[128]  S. Praharaj,et al.  Efficacy of adjunctive high frequency repetitive transcranial magnetic stimulation of left prefrontal cortex in depression: a randomized sham controlled study. , 2011, Journal of affective disorders.

[129]  F. Benedetti,et al.  How Placebos Change the Patient's Brain , 2011, Neuropsychopharmacology.

[130]  P. Fitzgerald,et al.  A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. , 2006, The American journal of psychiatry.

[131]  Bias in meta›analysis detected by a simple, graphical test , 1998 .

[132]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .